AR023338A1 - Composicion conteniendo ubiquinona adecuada para promover el transporte mejorado intramitocondrial de ubiquinonas y uso de la misma para preparar unacomposicion alimenticia/farmacologica - Google Patents

Composicion conteniendo ubiquinona adecuada para promover el transporte mejorado intramitocondrial de ubiquinonas y uso de la misma para preparar unacomposicion alimenticia/farmacologica

Info

Publication number: AR023338A1
Authority: AR; Argentina
Prior art keywords: food; prepare; intramitocondrial; accomposition; ubiquinones
Prior art date: 1998-10-21

Application number

ARP990105327A

Other languages

English (en)

Spanish (es)

Original Assignee

Sigma Tau Healthscience Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-21

Filing date

1999-10-21

Publication date

2002-09-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11343466&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR023338(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-10-21 Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa

2002-09-04 Publication of AR023338A1 publication Critical patent/AR023338A1/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Fats And Perfumes (AREA)

ARP990105327A 1998-10-21 1999-10-21 Composicion conteniendo ubiquinona adecuada para promover el transporte mejorado intramitocondrial de ubiquinonas y uso de la misma para preparar unacomposicion alimenticia/farmacologica AR023338A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT1998BO000596A IT1304406B1 (it)	1998-10-21	1998-10-21	Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.

Publications (1)

Publication Number	Publication Date
AR023338A1 true AR023338A1 (es)	2002-09-04

Family

ID=11343466

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP990105327A AR023338A1 (es)	1998-10-21	1999-10-21	Composicion conteniendo ubiquinona adecuada para promover el transporte mejorado intramitocondrial de ubiquinonas y uso de la misma para preparar unacomposicion alimenticia/farmacologica

Country Status (11)

Country	Link
US (1)	US6417233B1 (fr)
EP (1)	EP1123093B1 (fr)
AR (1)	AR023338A1 (fr)
AT (1)	ATE237323T1 (fr)
AU (1)	AU1074600A (fr)
DE (1)	DE69907010T2 (fr)
DK (1)	DK1123093T3 (fr)
ES (1)	ES2196874T3 (fr)
IT (1)	IT1304406B1 (fr)
PT (1)	PT1123093E (fr)
WO (1)	WO2000023069A1 (fr)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1307281B1 (it) *	1999-11-25	2001-10-30	Simonelli Giuseppe	Uso di ubichinone q10 per il trattamento locale e la prevenzione dipatalogie oftalmologiche secondarie alla terapia fotorefrattiva,
EA006429B1 (ru) *	2001-03-09	2005-12-29	Сосьете Де Продюи Нестле С.А.	Композиция для предупреждения или восстановления возрастных функциональных дефицитов у млекопитающих и способ ее применения
ES2210056T3 (es) *	2001-04-12	2004-07-01	Vesifact Ag	Preconcentrados en microemulsion y microemulsiones que contienen coenzima q10.
US6582723B2 (en) *	2001-05-03	2003-06-24	Wayne F. Gorsek	Cancer immune composition for prevention and treatment of individuals
JP4603192B2 (ja) *	2001-05-10	2010-12-22	株式会社カネカ	毛髪頭皮用組成物
DE60203494T2 (de) *	2001-05-30	2006-02-09	Laxdale Ltd.	Verwendung von coenzym q (ubiquinone) und eikosapentaensäure (epa) für die behandlung von non-hodgkin's lymphoma und psychiatrischen oder neurologischen erkrankungen
US7470659B2 (en) *	2001-12-07	2008-12-30	The Regents Of The University Of California	Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM)
US20030229062A1 (en) *	2001-12-07	2003-12-11	The Regents Of The University Of California	Treatments for age-related macular degeneration (AMD)
ITRM20010755A1 (it)	2001-12-20	2003-06-20	Simonelli Giuseppe	Uso del chinone q10 per il trattamento delle malattie oculari.
TW200302056A (en) *	2002-01-18	2003-08-01	Kaneka Corp	Method for stabilizing reduced coenzyme Q10 and composition therefor
US6974592B2 (en) *	2002-04-11	2005-12-13	Ocean Nutrition Canada Limited	Encapsulated agglomeration of microcapsules and method for the preparation thereof
US20050067726A1 (en) *	2002-11-04	2005-03-31	Nianxi Yan	Microcapsules having multiple shells and method for the preparation thereof
US20040208939A1 (en) *	2003-04-18	2004-10-21	Barry Sears	Novel dietary compositions to reduce inflammation
US7875291B1 (en)	2003-09-05	2011-01-25	Glu-Pro, Inc.	Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
ITTO20030140U1 (it) *	2003-09-16	2005-03-17	Interfila Srl	Matita cosmetica
TW200524579A (en) *	2003-11-28	2005-08-01	Kaneka Corp	Composition for protecting liver functions
WO2005065672A1 (fr) *	2004-01-08	2005-07-21	Kaneka Corporation	Composition antivieillissement
RS52792B (sr)	2004-01-22	2013-10-31	University Of Miami	Topijske formulacije koenzima q10 i postupci upotrebe
US7390507B2 (en) *	2004-04-13	2008-06-24	Ruwart Mary J	Compositions and methods for the treatment of radiation burns and other traumatic skin conditions
DE102004041270A1 (de) *	2004-08-26	2006-03-02	Merz Pharma Gmbh & Co. Kgaa	Ein Kapillar- Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung
US8034450B2 (en) *	2005-01-21	2011-10-11	Ocean Nutrition Canada Limited	Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
CA2596023A1 (fr) *	2005-01-27	2006-11-09	Ocean Nutrition Canada Ltd.	Derives de benzenediol d'acides gras et leurs methodes de conception et d'utilisation
WO2006109194A2 (fr) *	2005-01-27	2006-10-19	Ocean Nutrition Canada Ltd.	Composes de chrome et d'acides gras et leurs procedes de fabrication et d'utilisation
MX2007015006A (es) *	2005-06-01	2008-03-18	Edison Pharmaceuticals Inc	Sustancias terapeuticas activas redox para el tratamiento de enfermedades mitocondriales y otras condiciones o modulacion de biomarcadores de energia.
US9968120B2 (en) *	2006-05-17	2018-05-15	Dsm Nutritional Products Ag	Homogenized formulations containing microcapsules and methods of making and using thereof
ES2823728T3 (es) *	2005-09-15	2021-05-10	Ptc Therapeutics Inc	Variantes de cola de agentes terapéuticos con actividad redox para el tratamiento de enfermedades mitocondriales y otras afecciones y la modulación de biomarcadores de energía
CN101547687A (zh) *	2005-11-17	2009-09-30	生物药效率有限公司	生物相容的潜在乳化剂
ES2511772T3 (es)	2005-12-20	2014-10-23	Cenestra, Llc	Formulaciones de ácidos grasos omega-3
US20070184041A1 (en) *	2006-02-09	2007-08-09	Burja Adam M	Methods and compositions related to production of coenzyme q10
JP5374162B2 (ja)	2006-02-22	2013-12-25	エジソンファーマシューティカルズ，インコーポレイテッド	ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
GB0604647D0 (en) *	2006-03-08	2006-04-19	Shchepinov Mikhail	Stabilized food supplements and their derivatives
AU2007238985B2 (en) *	2006-04-07	2012-09-20	Dsm Nutritional Products Ag	Emulsions and microcapsules with substances having low interfacial tension, methods of making and using thereof
US8491888B2 (en) *	2006-05-05	2013-07-23	Softgel Formulators, Inc.	Highly absorbable coenzyme Q10 composition and method of producing same
CA2654031C (fr) *	2006-06-05	2016-05-24	Ocean Nutrition Canada Limited	Microcapsules a enveloppes ameliorees
KR100801057B1 (ko) *	2006-07-18	2008-02-04	삼성전자주식회사	컬러 보정 블럭을 구비하는 ｃｍｏｓ 이미지 센서 및 그이미지 센싱 방법
US8894993B2 (en) *	2006-08-04	2014-11-25	Natreon Inc.	Mitochondria-targeted antioxidants
US8383677B2 (en) *	2006-12-28	2013-02-26	Suntory Holdings Limited	Nerve-regenerating agent
US10166196B2 (en)	2007-01-10	2019-01-01	Dsm Nutritional Products Ag	Vegetarian microcapsules
HUP0700552A2 (en)	2007-08-27	2009-03-30	Janos Dr Feher	Method and composition inhibiting inflammation
US8343753B2 (en) *	2007-11-01	2013-01-01	Wake Forest University School Of Medicine	Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
KR100943652B1 (ko) *	2007-12-28	2010-02-25	(주)미토콘	생체이용율이 향상된 코엔자임큐10 함유 조성물
MX2010011032A (es)	2008-04-11	2011-03-01	Cytotech Labs Llc Star	Metodos y uso de induccion de apoptosis en celulas cancerigenas.
US8535659B1 (en)	2008-05-27	2013-09-17	Argent Development Group, Llc	Nutritional supplements for pregnant women
US8535660B1 (en)	2008-05-27	2013-09-17	Argent Development Group, Llc	Nutritional supplements for pregnant women
MX363223B (es)	2008-09-10	2019-03-15	Bioelectron Tech Corp	Tratamiento de trastornos generalizados del desarrollo con terapeuticos con actividad redox.
US8993625B2 (en)	2009-03-11	2015-03-31	Stable Solutions Llc	Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US20110071090A1 (en) *	2009-03-11	2011-03-24	Stable Solutions Llc	Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en)	2009-03-11	2015-05-19	Stable Solutions Llc	Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
IT1393419B1 (it) *	2009-03-19	2012-04-20	Medivis S R L	Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
US9005608B2 (en) *	2009-03-24	2015-04-14	Adds Pharmaceuticals Llc	Stabilized solubility-enhanced formulations for oral delivery
SG175993A1 (en) *	2009-05-11	2011-12-29	Berg Biosystems Llc	Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
JP5934102B2 (ja) *	2009-10-30	2016-06-15	レトロトップ、インコーポレイテッドＲｅｔｒｏｔｏｐｅ，Ｉｎｃ．	Ｐｕｆａ誘導体による酸化ストレス障害の緩和
CN105168135A (zh) *	2010-03-12	2015-12-23	博格有限责任公司	辅酶Q10(CoQ10)的静脉内制剂及其使用方法
JP6092844B2 (ja)	2011-04-04	2017-03-08	バーグエルエルシー	中枢神経系腫瘍の治療方法
AU2012249920B2 (en)	2011-04-26	2017-06-15	Biojiva Llc	Disorders implicating PUFA oxidation
EP2701696B1 (fr)	2011-04-26	2020-06-03	Retrotope, Inc.	Troubles de traitement compromis de l'énergie et déficiences mitochondriales
US10154983B2 (en)	2011-04-26	2018-12-18	Retrotope, Inc.	Neurodegenerative disorders and muscle diseases implicating PUFAs
EP3689342A1 (fr)	2011-04-26	2020-08-05	Retrotope, Inc.	Rétinopathies oxydatives
EP2720689A4 (fr) *	2011-06-14	2014-11-26	Edison Pharmaceuticals Inc	Dérivés de catéchol pour le traitement de maladies liées au stress oxydatif
MX351781B (es)	2011-06-17	2017-10-30	Berg Llc	Composiciones farmaceuticas inhalables.
US20140274966A1 (en) *	2013-03-14	2014-09-18	Hygia Pharmaceuticals, Llc	Drink Product Containing Genistein and Use Thereof
MX380565B (es)	2013-04-08	2025-03-12	Berg Llc	Terapias combinadas de coenzima q10 para el tratamiento de cáncer.
CA2916513A1 (fr) *	2013-07-03	2015-01-08	Barrie Tan	Coq10 (ubiquinone, ubiquinol), vitamine a (acide retinoique, retinol), vitamine e (tocotrienol, tocopherol) et procedes pour les utiliser
CN105705162A (zh)	2013-09-04	2016-06-22	博格有限责任公司	通过持续输注辅酶q10来治疗癌症的方法
US9138453B2 (en)	2013-10-14	2015-09-22	Biomarker Pharmaceuticals, Inc.	Nutrient combinations for affecting an aging process
US20170189350A1 (en)	2015-11-16	2017-07-06	Berg Llc	Methods of treatment of temozolomide-resistant glioma using coenzyme q10
CN113214084A (zh)	2015-11-23	2021-08-06	乐巢拓普有限公司	1,4-二烯体系的位点特异性同位素标记
DE202015106479U1 (de)	2015-11-29	2016-03-09	Cathleen Straßburger	Stapelhilfe und Abdeckhaube für den Transport von Cateringmaterial zum Kunden
CA3008849A1 (fr)	2015-12-17	2017-06-22	Bioelectron Technology Corporation	Derives fluoroalkyle, fluoroalcoxy, phenoxy, heteroaryloxy, alcoxy, et amine 1,4-benzoquinone pour le traitement de troubles du stress oxydatif
IL321252A (en)	2020-02-21	2025-08-01	Retrotope Inc	Processes for isotopic alteration of polyunsaturated fatty acids and their derivatives
US12109194B2 (en)	2021-02-05	2024-10-08	Biojiva Llc	Synergistic combination therapy for treating ALS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5618914A (en)	1979-07-25	1981-02-23	Eisai Co Ltd	Ubidecarenone composition having good absorbability
DE3224619A1 (de)	1981-07-14	1983-05-19	Freund Industrial Co., Ltd., Tokyo	Orale pharmazeutische zusammensetzung
JP2643217B2 (ja) *	1988-01-22	1997-08-20	エーザイ株式会社	脂溶性物質水性液
US5895652A (en)	1996-07-29	1999-04-20	Longevity Institute International	Method of metabolic adjuvanation and cellular repair
NO304009B1 (no) *	1997-02-04	1998-10-12	Gunnar Volden	Hudpreparat
CA2260397A1 (fr) *	1999-01-29	2000-07-29	Atlantis Marine Inc.	Methode pour convertir l'huile fondue de triglyceride provenant de sources marines en huile alimentaire douce et stable

1998
- 1998-10-21 IT IT1998BO000596A patent/IT1304406B1/it active
1999
- 1999-10-19 ES ES99954343T patent/ES2196874T3/es not_active Expired - Lifetime
- 1999-10-19 WO PCT/IT1999/000331 patent/WO2000023069A1/fr not_active Ceased
- 1999-10-19 DK DK99954343T patent/DK1123093T3/da active
- 1999-10-19 EP EP99954343A patent/EP1123093B1/fr not_active Revoked
- 1999-10-19 AU AU10746/00A patent/AU1074600A/en not_active Abandoned
- 1999-10-19 DE DE69907010T patent/DE69907010T2/de not_active Revoked
- 1999-10-19 PT PT99954343T patent/PT1123093E/pt unknown
- 1999-10-19 US US09/807,918 patent/US6417233B1/en not_active Expired - Fee Related
- 1999-10-19 AT AT99954343T patent/ATE237323T1/de active
- 1999-10-21 AR ARP990105327A patent/AR023338A1/es unknown

Also Published As

Publication number	Publication date
AU1074600A (en)	2000-05-08
DE69907010D1 (de)	2003-05-22
US6417233B1 (en)	2002-07-09
WO2000023069A1 (fr)	2000-04-27
IT1304406B1 (it)	2001-03-19
ES2196874T3 (es)	2003-12-16
EP1123093B1 (fr)	2003-04-16
ITBO980596A0 (it)	1998-10-21
DE69907010T2 (de)	2004-02-19
DK1123093T3 (da)	2003-08-11
PT1123093E (pt)	2003-09-30
ATE237323T1 (de)	2003-05-15
EP1123093A1 (fr)	2001-08-16
ITBO980596A1 (it)	2000-04-21

Publication	Publication Date	Title
AR023338A1 (es)	2002-09-04	Composicion conteniendo ubiquinona adecuada para promover el transporte mejorado intramitocondrial de ubiquinonas y uso de la misma para preparar unacomposicion alimenticia/farmacologica
ES2169197T3 (es)	2002-07-01	Composicion farmaceutica que comprende una alcanoil l-carnitina en combinacion con un acido graso poliinsaturado de la serie omega-3 para la prevencion y el tratamiento de trastornos del metabolismo de los lipidos.
ES2161085T3 (es)	2001-11-16	Formulaciones que contienen oxaliplatino.
ES2145118T3 (es)	2000-07-01	Derivados de acidos grasos y composiciones farmaceuticas que los contienen.
ES2165870T3 (es)	2002-04-01	Alimentos de uso medico destinados para el mantenimiento nutricional de niños/adultos que padecen enfermedades metabolicas.
ES2158084T3 (es)	2001-09-01	Preparaciones vehiculo lipofilicas.
CR6310A (es)	2003-11-25	1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas
MX9301087A (es)	1994-01-31	Efecto de la distribucion del tamaño de particulas de esteres de celulosa sobre el buen sabor de las composiciones.
ES2139800T3 (es)	2000-02-16	Preparaciones farmaceuticas liposomales inyectables.
IL117773A0 (en)	1996-08-04	Solid lipid compositions of coenzyme q10 for enhanced oral bioavailability
ES2158908T3 (es)	2001-09-16	Formulaciones en aerosol sin clorofluorocarbonos.
HUP0002486A1 (hu)	2000-12-28	Lipofil vegyületeket tartalmazó ön-emulgeáló készítmény
ES2168157T3 (es)	2002-06-01	Alimento o suplemento nutritivo, su procedimiento de preparacion y sus utilizaciones.
ATE236627T1 (de)	2003-04-15	Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
ES2136100T3 (es)	1999-11-16	Composicion lipida para productos cosmeticos que contienen trigliceridos de acidos grasos insaturados.
CO4130180A1 (es)	1995-02-13	Composiciones para el cuidado de la piel que contienen una emulsion de agua en aceite y un retinoide
AR017205A1 (es)	2001-08-22	ANILIDAS MIMÉTICAS DE ÁCIDO RETINOICO, PROCESOS PARA PREPARAR DICHOS COMPUESTOS, COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN, UN PROCESO PARA PREPARAR DICHAS COMPOSICIONES Y EL USO DE DICHOS COMPUESTOS EN LA ELABORACIoN DE MEDICAMENTOS.
ES2187595T3 (es)	2003-06-16	Preparado para la alimentacion.
CO5140102A1 (es)	2002-03-22	Formulacion farmaceutica en forma de pasta semisolida estabilizada para administracion oral que comprende omeprazol, de dos a cuatro agentes basificantes, un agente espesante y un vehiculo aceitoso hidrofobico
BR9800728A (pt)	1999-07-20	Composição para tratamento de cabelo e usos da composição e de ingredientes como precursores de ácido graxo de lipídeo integral de cabelo em uma composição para tratamento de cabelo
BR0110664A (pt)	2003-03-25	Composição de gordura alimentìcia escoável, e, uso de uma combinação de um éster de ácido cìtrico de glicerìdeos parciais de ácido graxo e um sal
IT1263840B (it)	1996-09-04	Formulazioni orali di ubidecarenone in forma di capsule
ES2148123T3 (es)	2003-01-16	Composiciones cosmeticas para la prevencion y terapia de la perdida del cabello.
AR021921A1 (es)	2002-09-04	Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos y budesonido.
AR012546A1 (es)	2000-11-08	Utilizacion de al menos un compuesto seleccionado entre el grupo que comprende los sogaoles y los gingeroles para la preparacion de una composiciondesodorante, sogaol, extracto bruto y extracto purificado que contiene el sogaol y la composicion desodorante obtenida.